A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With Dyslipidemia

This study has been terminated.
(The study was terminated prior to completion to focus on the development of a controlled release formulation.)
Sponsor:
Information provided by:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
ClinicalTrials.gov Identifier:
NCT00231621
First received: September 30, 2005
Last updated: June 6, 2011
Last verified: April 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2002
  Estimated Primary Completion Date: No date given